TAIKO PHARMACEUTICAL CO.,LTD. (4574.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

25.5x

EV/EBITDA

11.1x

Market Cap

JPY 12.76B

MomentumView details →

1D Return

−1.17%

YTD Return

−14.43%

RSI (14)

40.6

ValuationView details →

P/E (Fwd)

25.5x

EV/EBITDA

11.1x

Market Cap

JPY 12.76B

RSI (14)

40.6

MomentumView details →

1D Return

−1.17%

YTD Return

−14.43%

ProfitabilityView details →

Gross Margin

54.42%

Net Margin

14.43%

EBITDA Margin

11.32%

ROE (TTM)

10.84%

ROA (TTM)

7.52%

Asset Turnover

0.53x

GrowthView details →

Revenue YoY

+1.67%

EPS YoY

+2.66%

FCF YoY

—

Revenue CAGR 3Y

+8.27%

EPS CAGR 3Y

+2.68%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.09x

Current Ratio

3.36x

Quick Ratio

3.24x

Div Yield

1.30%

Div Rate

JPY 3.30

Div Growth 1Y

−86.80%

Financials snapshotView financials →

Revenue (TTM)

6.16B

Net Income (TTM)

536.00M

Op. CF (TTM)

—

Next earningsNov 6, 2026 →

Latest newsMore news →

Daiko Pharmaceutical announced on August 25 that it will apply to change its market segment from the Tokyo Stock Exchange Prime Market to the Standard Market, because its free-float market capitalization fell below the Prime maintenance standard.11d ago

Taiko Pharmaceutical reported a 2.1-fold increase in recurring profit for the first half and a 15-fold increase for the April-June quarter.23d ago

Similar companies

RaQualia Pharma Inc.4579.T STELLA PHARMA CORPORATION4888.T AnGes,Inc.4563.T MediciNova,Inc.4875.T Renascience Inc.4889.T WAKAMOTO PHARMACEUTICAL CO.,LTD.4512.T Find similar companies →

Latest newsMore news →

Daiko Pharmaceutical announced on August 25 that it will apply to change its market segment from the Tokyo Stock Exchange Prime Market to the Standard Market, because its free-float market capitalization fell below the Prime maintenance standard.11d ago Taiko Pharmaceutical reported a 2.1-fold increase in recurring profit for the first half and a 15-fold increase for the April-June quarter.23d ago